PTSD Trial, Recruiting NCT06944262 Sponsor: Lille University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06944262
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients (Part 1):

  • Adults aged 18 or older
  • People diagnosed with breast, gynaecological, testicular, or digestive cancer within the last 4 months, at the point when their treatment plan was first explained to them
  • People whose cancer requires active cancer treatment
  • People who are starting their cancer treatment at the Oscar Lambret Center
  • People whose cancer has not spread to the brain or central nervous system
  • People with a favourable prognosis score (PRONOPALL score of 3 or less) or an expected survival of more than 6 months (confirm with trial site)
  • People who have signed consent to participate and are covered by French social security
  • People who are able to identify a caregiver — such as a family member, friend, or other person who has helped support them since their diagnosis
  • People who have access to a computer or tablet with an internet connection for completing online questionnaires; a webcam is needed if video participation is preferred, or a smartphone capable of video calls if phone-based video is preferred

For caregivers (Part 1):

  • Adults aged 18 or older
  • People designated by the patient as their primary caregiver (a family member, friend, or other person who has helped care for the patient since diagnosis)
  • People who have signed consent to participate
  • People who have access to a computer or tablet with an internet connection; a webcam is needed if video participation is preferred, or a smartphone capable of video calls if phone-based video is preferred

For patient focus groups (Part 2):

  • Adults who have or have had cancer
  • Members of a local patient association or the Oscar Lambret Center's patient partners committee, or people who completed all three steps of Part 1 of this study
  • People with access to a computer or tablet with a camera and internet connection
  • People who have given consent to participate

For caregiver focus groups (Part 2):

  • Adults who are, or have been, a caregiver for a person with cancer
  • Members of a local caregivers' association, or people who completed all three steps of Part 1 of this study
  • People with access to a computer or tablet with a camera and internet connection
  • People who have given consent to participate

For healthcare professional focus groups (Part 2):

  • Medical or paramedical staff at the Oscar Lambret Center, or non-hospital professionals involved in the medical or psychological care of patients
  • Professionals who are not already involved in running this study
  • People with access to a computer or tablet with a camera and internet connection
  • People who have given consent to participate

Who may not be able to join:

For patients (Part 1):

  • People whose cancer has spread to the brain or the membranes surrounding the brain
  • People whose cancer has come back after a previous illness (recurrence)
  • People living with a psychiatric or neurological condition that may affect their ability to reason or make judgements — such as a psychotic disorder, autism spectrum disorder, or intellectual disability
  • People who, as confirmed by medical staff, are unable to complete questionnaires due to psychological or physical reasons
  • People who are under a custodial sentence, guardianship, or legal protection for vulnerable adults

For caregivers (Part 1):

  • People living with, or suspected of having, a psychiatric or neurological condition that may affect their ability to reason or make judgements — such as a psychotic disorder, autism spectrum disorder, or intellectual disability (this criterion is self-reported; no additional tests are required)
  • People who are unable to complete questionnaires due to psychological or physical reasons, or where there is a suspicion of this (self-reported; no additional tests are required)
  • People who are under a custodial sentence, guardianship, or legal protection for vulnerable adults

For focus group participants from Part 1:

  • People who did not complete all three required measurement points during Part 1 of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lille University
Registry
ClinicalTrials.gov
Start date
2 April 2025
Est. completion
5 February 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

PTSD Checklist for DSM-5 (PCL5)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov